230 related articles for article (PubMed ID: 28263871)
1. Effects of statins on the immunoglobulin G glycome.
Keser T; Vučković F; Barrios C; Zierer J; Wahl A; Akinkuolie AO; Štambuk J; Nakić N; Pavić T; Periša J; Mora S; Gieger C; Menni C; Spector TD; Gornik O; Lauc G
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1152-1158. PubMed ID: 28263871
[TBL] [Abstract][Full Text] [Related]
2. N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events.
Hoshi RA; Plavša B; Liu Y; Trbojević-Akmačić I; Glynn RJ; Ridker PM; Cummings RD; Gudelj I; Lauc G; Demler OV; Mora S
Circ Res; 2024 Mar; 134(5):e3-e14. PubMed ID: 38348651
[TBL] [Abstract][Full Text] [Related]
3. Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.
Rudman N; Kaur S; Simunović V; Kifer D; Šoić D; Keser T; Štambuk T; Klarić L; Pociot F; Morahan G; Gornik O
Diabetologia; 2023 Jun; 66(6):1071-1083. PubMed ID: 36907892
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-Associated Changes of IgG and Serum N-Glycosylation in Camel (Camelus dromedarius).
Adamczyk B; Albrecht S; Stöckmann H; Ghoneim IM; Al-Eknah M; Al-Busadah KA; Karlsson NG; Carrington SD; Rudd PM
J Proteome Res; 2016 Sep; 15(9):3255-65. PubMed ID: 27428249
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Analysis of the IgG N-Glycome by UPLC-FLR.
Pučić-Baković M
Methods Mol Biol; 2017; 1503():21-29. PubMed ID: 27743356
[TBL] [Abstract][Full Text] [Related]
6. Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study.
Deriš H; Cindrić A; Lauber M; Petrović T; Bielik A; Taron CH; van Wingerden M; Lauc G; Trbojević-Akmačić I
Glycobiology; 2021 Sep; 31(9):1062-1067. PubMed ID: 34132802
[TBL] [Abstract][Full Text] [Related]
7. Plasma N-glycome composition associates with chronic low back pain.
Trbojević-Akmačić I; Vučković F; Vilaj M; Skelin A; Karssen LC; Krištić J; Jurić J; Momčilović A; Šimunović J; Mangino M; De Gregori M; Marchesini M; Dagostino C; Štambuk J; Novokmet M; Rauck R; Aulchenko YS; Primorac D; Kapural L; Buyse K; Mesotten D; Williams FMK; van Zundert J; Allegri M; Lauc G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2124-2133. PubMed ID: 29981899
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes Mellitus is Associated with the Immunoglobulin G N-Glycome through Putative Proinflammatory Mechanisms in an Australian Population.
Li X; Wang H; Russell A; Cao W; Wang X; Ge S; Zheng Y; Guo Z; Hou H; Song M; Yu X; Wang Y; Hunter M; Roberts P; Lauc G; Wang W
OMICS; 2019 Dec; 23(12):631-639. PubMed ID: 31526239
[TBL] [Abstract][Full Text] [Related]
9. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
Pucić M; Knezević A; Vidic J; Adamczyk B; Novokmet M; Polasek O; Gornik O; Supraha-Goreta S; Wormald MR; Redzić I; Campbell H; Wright A; Hastie ND; Wilson JF; Rudan I; Wuhrer M; Rudd PM; Josić D; Lauc G
Mol Cell Proteomics; 2011 Oct; 10(10):M111.010090. PubMed ID: 21653738
[TBL] [Abstract][Full Text] [Related]
10. N-glycosylation of immunoglobulin G predicts incident hypertension.
Kifer D; Louca P; Cvetko A; Deriš H; Cindrić A; Grallert H; Peters A; Polašek O; Gornik O; Mangino M; Spector TD; Valdes AM; Padmanabhan S; Gieger C; Lauc G; Menni C
J Hypertens; 2021 Dec; 39(12):2527-2533. PubMed ID: 34285147
[TBL] [Abstract][Full Text] [Related]
11. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.
Mora S; Glynn RJ; Hsia J; MacFadyen JG; Genest J; Ridker PM
Circulation; 2010 Mar; 121(9):1069-77. PubMed ID: 20176986
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.
Kones R
Drug Des Devel Ther; 2010 Dec; 4():383-413. PubMed ID: 21267417
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma.
Pan H; Wu Z; Zhang H; Zhang J; Liu Y; Li Z; Feng W; Wang G; Liu Y; Zhao D; Zhang Z; Liu Y; Zhang Z; Liu X; Tao L; Luo Y; Wang X; Yang X; Zhang F; Li X; Guo X
Front Immunol; 2023; 14():981861. PubMed ID: 36999031
[TBL] [Abstract][Full Text] [Related]
14. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC.
Saldova R; Asadi Shehni A; Haakensen VD; Steinfeld I; Hilliard M; Kifer I; Helland A; Yakhini Z; Børresen-Dale AL; Rudd PM
J Proteome Res; 2014 May; 13(5):2314-27. PubMed ID: 24669823
[TBL] [Abstract][Full Text] [Related]
15. Extensive weight loss reduces glycan age by altering IgG N-glycosylation.
Greto VL; Cvetko A; Štambuk T; Dempster NJ; Kifer D; Deriš H; Cindrić A; Vučković F; Falchi M; Gillies RS; Tomlinson JW; Gornik O; Sgromo B; Spector TD; Menni C; Geremia A; Arancibia-Cárcamo CV; Lauc G
Int J Obes (Lond); 2021 Jul; 45(7):1521-1531. PubMed ID: 33941843
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease.
Pavić T; Dilber D; Kifer D; Selak N; Keser T; Ljubičić Đ; Vukić Dugac A; Lauc G; Rumora L; Gornik O
J Transl Med; 2018 Nov; 16(1):323. PubMed ID: 30463578
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.
Ridker PM; Pradhan A; MacFadyen JG; Libby P; Glynn RJ
Lancet; 2012 Aug; 380(9841):565-71. PubMed ID: 22883507
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders.
Mittermayr S; Lê GN; Clarke C; Millán Martín S; Larkin AM; O'Gorman P; Bones J
J Proteome Res; 2017 Feb; 16(2):748-762. PubMed ID: 27936757
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation (Glycomic) Biomarkers for Cardiometabolic Health: A Community-Based Study of Immunoglobulin G
Wang H; Li X; Wang X; Liu D; Zhang X; Cao W; Zheng Y; Guo Z; Li D; Xing W; Hou H; Wu L; Song M; Zhong Z; Wang Y; Tan X; Lauc G; Wang W
OMICS; 2019 Dec; 23(12):649-659. PubMed ID: 31313980
[TBL] [Abstract][Full Text] [Related]
20. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
